Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-052674
Filing Date
2025-04-10
Accepted
2025-04-10 07:30:16
Documents
17
Period of Report
2025-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A amrn-20250410.htm   iXBRL DEF 14A 2135060
2 GRAPHIC img154157161_0.jpg GRAPHIC 7999
3 GRAPHIC img154157161_1.jpg GRAPHIC 105009
4 GRAPHIC img154157161_2.jpg GRAPHIC 107803
5 GRAPHIC img154157161_3.jpg GRAPHIC 89407
  Complete submission text file 0000950170-25-052674.txt   4431662

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20250410.xsd EX-101.SCH 41071
19 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20250410_htm.xml XML 534143
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21392 | Film No.: 25826495
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)